Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs Warfarin After Bioprosthetic Heart Valve Replacement
NCT07431762Phase 4Recruiting
- Sponsor
- Asan Medical Center
- Start
- Jun 2026
- Primary completion
- Oct 2030
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of aspirin in thrombosis (2 arms), sponsored by Asan Medical Center. Primary endpoint: Composite Endpoint of Clinical Events at 6 months. Started Jun 2026; status: recruiting.
02
Drugs
aspirin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT07431762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07431762.